Gpt Healthcare Limited · NSE:GPTHEALTH
Gpt Healthcare — Q3 & 9M FY26 Earnings Presentation
32 slides from Gpt Healthcare's earnings presentation, Feb 2, 2026
Slide 1: Cover letter to stock exchanges
GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2025-26 February 2, 2026 The Department of Corporate Services Natio
Slide 2: GPT Healthcare Limited Investor Presentation Q3 & 9M'FY26
GPT HEALTHCARE LIMITED Investor Presentation Q3 & 9M’FY26
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by GPT Healthcare Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secur
Slide 4: Key Highlights of the Period-9M'FY26
Key Highlights of the Period-9M’FY26 ARPOB increased 6% YoY to ₹38,797 reflecting strengthened clinical offerings and continued operational efficiencies. Overall network occupancy was 45%. However, excluding the Raipur Hospital, which started during Q1’FY26, the network occupancy marginally improved
Slide 5: Company Overview
Company Overview GPT Healthcare Limited is a fast-growing hospital platform in Eastern India, operating five, neighborhood tertiary-care hospitals located within densely populated residential areas. 719 115 Designed around a proximity-based model, its hospitals offer Beds- total capacity Full time c
Slide 6: Financial Snapshot
a S ° bo Financial Snapshot
Slide 7: Financial Snapshot for Q3 & 9M'FY26
Financial Snapshot for Q3 & 9M’FY26 Q3’FY26 Revenue EBITDA & EBITDA Margin PAT & PAT Margin Rs 121.6 Cr Rs 22.1 Cr Rs 9.4 Cr (18.2 % Margin) (7.7 % Margin) YoY 16.8% YoY -4.4% YoY -23.5% ARPOB Occupancy Rate % Dum Dum Rs 39,613 45.93 % Agartala Salt lake 9M’FY26 Howrah Jamshedpur Revenue EBITDA & EB
Slide 8: Hospital-wise Performance for Q3 & 9M'FY26
Hospital-wise Performance for Q3 & 9M’FY26 Salt lake Hospital Agartala Hospital Dum-Dum Hospital Howrah Hospital Raipur Hospital West Bengal Tripura West Bengal West Bengal Chhattisgarh Year of 2000 2011 2013 2019 2025 commissioning FY26 Q3 9M Q3 9M Q3 9M Q3 9M Q3 9M Bed capacity 85 205 155 116 158
Slide 9: Hospital Portfolio
a S ° bo Hospital Portfolio
Slide 10: ILS Salt Lake Hospital
ILS Salt Lake Hospital 85-bed tertiary surgical hospital with 17 ICUs and 3 OTs, scaled from an 8-bed facility. Clinical focus on robotic gastro and bariatric surgeries, enabling higher case 85 17 & 3 complexity. Total Number of beds ICU & OTS Specialized care offerings including diabetic foot care
Slide 11: ILS Agartala Hospital
ILS Agartala Hospital 205-bed, corporate hospital with 66 ICUs, 8 OTs and 1 Cath lab, offering large- scale critical care capacity Clinical leadership in the state, with multiple first-in-Tripura procedures 66,8 &1 including leadless dual chamber implantation and complex vascular stenting ICU,OTS &
Slide 12: ILS Dum Dum Hospital
ILS Dum Dum Hospital 155-bed, tertiary facility with strong focus on multispecialty and critical care delivery Licensed for renal transplants with upgraded gastroenterology services, 155 53, 4 &1 forming the core specialty base Total Number of beds ICU,OTS & Cath Labs Known for renal and cardiac car
Slide 13: ILS Howrah Hospital
ILS Howrah Hospital 116 Bed, Multi-specialty tertiary care hospital in Howrah, located near Railway Station, with no competing hospital within a 5-km radius Launched robot-assisted orthopedic surgery, including robotic knee 116 43,3 &1 replacements. Total Number of beds ICU,OTS & Cath Labs Recognize
Slide 14: ILS Raipur Hospital
ILS Raipur Hospital 158 Bed, Quaternary care hospital commencing its operations from May 2025, at Pachpedi Naka, serving a large catchment across Raipur, Bilaspur, Durg and Bhilai The Renal transplant program is commenced and chemotherapy & oncology surgeries fully operational 158 5&1 Progressive ex
Slide 15: Our cutting-edge investments
Our cutting-edge investments MAKO – Orthopedic robot for joint Robotic assisted GI Surgery 3 Tesla MRI and Cath Lab Facilities replacement Well- equipped ICU’s and NICU’s Radiation and oncology State-of-the-art Operation theatres 14
Slide 16: Technology-Enabled Healthcare Innovation
Technology-Enabled Healthcare Innovation SPARSH – Healthcare ILS-My Health app HMIS enhancing Advancing healthcare at home for senior enhancing patient efficiency and through cutting edge citizens convenience patient care technology A home healthcare service for senior Hospital Management Informatio
Slide 17: Emerging Markets, Proposition & Path Ahead
Emerging Markets, Proposition & Path Ahead
Slide 18: Emerging Opportunities in Industry
Emerging Opportunities in Industry High – Multiple Growth expected Medical Tourism growth corridor Eastern India is emerging as a hub for international patients Attractive 20x–30x EBITDA valuations amid strong growth in from Bangladesh, Nepal, Bhutan with its market expected to India’s healthcare ma
Slide 19: Emerging Opportunities in Industry
Emerging Opportunities in Industry Global Health-care demand Work Force shortage Persistent shortages of doctors and nurses are accelerating The global healthcare market is projected to reach $ 665.37 the shift toward organized healthcare platforms that can billion by 2028. attract talent, standardi
Slide 20: Key Investment Proposition
Key Investment Proposition Eastern India Expand in Eastern India by leveraging strong regional brand Market Leadership equity and capitalizing on rising healthcare demand. Strategic Leverage strategic locations in dense residential area near Positioning transport hubs to create easy patient access.
Slide 21: Path Ahead
Path Ahead Next-Gen Care Asset-Light Quality- Led Returns Delivery Expansion Unlocking Operating Rapid Capacity Balanced leverage Robotic surgery Expansion Maintain long term specialty mix Rapid scale-up with integrated ROE and ROCE ~ 25% low capital intensity as part of a alongside ongoing through
Slide 22: Short-term Outlook
Short- term Outlook Strategic Expansion Outlook • Jamshedpur Hospital: MoU signed for a 150-bed facility with INR 75 crore investment, targeted commissioning by end-FY27. • Planned entry into Tier II cities (Uttar Pradesh, Assam, Odisha) and select Tier I locations in Eastern India. • Land and build
Slide 23: Financial & Operational Highlights
Financial & Operational Highlights
Slide 24: Key financial metrics for Q3 & 9M'FY26
Key financial metrics for Q3 & 9M’FY26 Revenue from Operations (INR Cr) EBITDA (INR Cr) & EBITDA Margin (%) PAT (INR Cr) & PAT Margin (%) 21.8% 23% 22.1% 22.2% 18.2% 22.2% 18.6% 10.6% 11.8% 12.0% 11.7% 7.7% 11.8% 7.9% 400 407 93 92 48 50 361 351 80 313 70 65 39 37 28 122 104 23 22 12 9 FY23 FY24 FY2
Slide 25: Key operational metrics for Q3 & 9M'FY26
Key operational metrics for Q3 & 9M’FY26 No of Beds & Occupancy Rate (%) Average length of stay (days) Average Revenue per Occupied Bed (INR) 58.9% 58.9% 53.1% 53.8% 45.1% 4.5 4.22 3.95 719 4.0 3.54 3.54 3.48 37,180 36,671 38,797 3.5 32,947 561 561 561 561 29,671 3.0 2.5 2.0 1.5 1.0 0.5 0.0 FY23 FY2
Slide 26: Revenue distribution of care services across hospitals
Revenue distribution of care services across hospitals FY24 FY25 9M’FY26 5% 3% 4% 6% 7% 8% 19% 19% 18% 4% 5% 9% 7% 8% 8% 7% 5% 17% 4% 22% 4% 20% 5% 3% 5% 4% 5% 10% 13% 11% Internal Medicine & Diabetology Critical Care Gynaecology and obstetrics Neurosciences Nephrology with Renal transplants Pediatr
Slide 27: Profit and Loss Highlights – Q3 & 9M'FY26
Profit and Loss Highlights – Q3 & 9M’FY26 Particulars Q3FY26 Q3FY25 Y-o-Y Q2 FY26 Q-o-Q 9MFY26 9MFY25 Y-o-Y Revenue from Operations 120.2 102.2 118.9 346.2 305.7 Other Operating Income 1.4 1.9 1.3 4.3 6.9 Total Revenue 121.6 104.1 16.81% 120.2 1.11% 350.5 312.6 12.12% Cost of Material Consumed 23.5
Slide 28: Historical Profit and Loss Statement
Historical Profit and Loss Statement Particulars FY23 FY24 FY25 Revenue from Operations 361.0 400.2 407.1 Other Operating Income 5.7 5.3 8.5 Total Revenue 366.7 405.7 415.6 Cost of Material Consumed 75.9 83.0 78.8 Employee Benefits Expenses 62.0 68.9 73.0 Other Expenses 148.8 160.5 171.9 EBITDA 80.0
Slide 29: Professional and Experienced Leadership – Board of Directors
Professional and Experienced Leadership –Board of Directors Dr. Om Tantia Shree Gopal Tantia Anurag Tantia Dr. Aruna Tantia Dr. Ghanshyam Goyal Chairman & Managing Director Vice Chairman Executive Director Non - Executive Director Non - Executive Director • Founding member of ILS Hospitals • More th
Slide 30: Awards & Accreditations
Awards & Accreditations Great place to Leading chain of The Eastern India work Award multispecialty award Best Health care brand Best Employer Brand Awards NABH Nursing Excellence The Happening awards Eastern India Quality Brand of Certification Bengal Brilliance Leadership Awards India Award 29
Slide 31: Stock Information
Stock Information Share Price Movement Shareholding Pattern (Dec’25) 200 Interim Dividend of Re.1/- 180 25.5% 160 140 120 6.2% 2.7% 65.6% Price in Rs 100 80 Promoters FII DII Public 60 40 Stock Data (As on 30th Jan, 2026) BSE/NSE Code 544131 | GPTHEALTH 20 CMP (Rs) 128.4 0 01-Nov-24 08-Feb-25 06-Jan
Slide 32: Thank You
COMPANY : GPT HEALTHCARE LIMITED CIN : L70101WB1989PLC047402 www.ilshospitals.com www.ilshospitals.com Mr. Arihant Sonthalia Ms. Mansi Mohta ir@gptgroup.co.in ir@gptgroup.co.in INVESTOR RELATIONS ADVISORS : MUFG Intime India Private Limited A part of MUFG Corporate Markets, a division of MUFG Pensio